Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash	$ 9,470	$ 37,174
Prepaid expense	70,001
Total current assets	79,471	37,174
Investment held in Trust Account	45,052,492	44,388,583
TOTAL ASSETS	45,131,963	44,425,757
Current liabilities:
Accrued liabilities	92,627	114,310
Total current liabilities	930,396	419,279
Deferred underwriting compensation	1,868,750	1,868,750
TOTAL LIABILITIES	2,799,146	2,288,029
Commitments and contingencies (Note 7)
Ordinary shares subject to possible redemption, 4,201,655 and 4,201,655 shares issued and outstanding at redemption value of $10.72 and $10.56 as of March 31, 2026 and December 31, 2025, respectively	45,052,492	44,388,583
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 500,000 shares authorized; no shares issued and outstanding
Ordinary shares, $0.0001 par value; 55,000,000 shares authorized; 1,749,375 shares issued and outstanding as of March 31, 2026 and December 31, 2025 (excluding 4,201,655 and 4,201,655 shares subject to possible redemption), respectively	175	175
Accumulated deficit	(2,719,850)	(2,251,030)
Total Shareholders’ Deficit	(2,719,675)	(2,250,855)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	45,131,963	44,425,757
Related Party
Current liabilities:
Promissory note – related party	400,000	100,000
Due to related party	$ 437,769	$ 204,969